KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Clover Health Investments (CLOV) Debt to Equity (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Debt to Equity for 5 consecutive years, with $0.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Debt to Equity changed N/A year-over-year to $0.0, compared with a TTM value of $0.0 through Dec 2024, changed N/A, and an annual FY2024 reading of $0.0, changed N/A over the prior year.
  • Debt to Equity was $0.0 for Q4 2024 at Clover Health Investments, down from $0.0 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.06 in Q2 2021 and bottomed at -$0.21 in Q4 2020.
  • Average Debt to Equity over 5 years is $0.01, with a median of $0.04 recorded in 2021.
  • The sharpest move saw Debt to Equity skyrocketed 387.83% in 2022, then plummeted 90.78% in 2023.
  • Year by year, Debt to Equity stood at -$0.21 in 2020, then soared by 119.87% to $0.04 in 2021, then tumbled by 86.91% to $0.01 in 2022, then decreased by 23.67% to $0.0 in 2023, then tumbled by 74.38% to $0.0 in 2024.
  • Business Quant data shows Debt to Equity for CLOV at $0.0 in Q4 2024, $0.0 in Q1 2023, and $0.01 in Q4 2022.